Award
Portfolio Data
Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need
Award Year: 2020
UEI: CAGMXNKG7XJ1
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Congressional District: 3
Tagged as:
SBIR
Phase I
Awarding Agency
DOD
Branch: USAF
Total Award Amount: $49,982
Contract Number: FA8649-20-P-0040
Agency Tracking Number: FX192-SO1-0505
Solicitation Topic Code: AF193-CSO1
Solicitation Number: DoD SBIR X19.2
Abstract
Quick-Med Technologies, Inc. (Gainesville, FL) is an innovative life sciences company specializing in the development of next-generation antimicrobial technologies for the healthcare, consumer, and Government markets. Quick-Med (QMT) has developed the world's most advanced antimicrobial technologies that combat microbial growth in a variety of broad-based products. Our technology is always designed to be safe for the environment and public health. By utilizing biomimetic chemistries, broad and long-lasting antimicrobial efficacy can be provided at affordable cost, without concern about bacterial resistance, or environmental toxicity.
Award Schedule
-
2020
Solicitation Year -
2020
Award Year -
December 12, 2019
Award Start Date -
December 12, 2020
Award End Date
Principal Investigator
Name: Bernd Liesenfeld
Phone: (352) 514-8864
Email: bliesenfeld@quickmedtech.com
Business Contact
Name: Bernd Liesenfeld
Phone: (352) 379-0611
Email: bliesenfeld@quickmedtech.com
Research Institution
Name: N/A